Elizabeth Smyth in Cairo for ISCO 2026 with ESMO and EORTC Presidents
Elizabeth Smyth/LinkedIn

Elizabeth Smyth in Cairo for ISCO 2026 with ESMO and EORTC Presidents

Elizabeth Smyth, Clinical Lead at the Oxford Clinical Trials Office, shared a post on LinkedIn:

“After a few years of virtual meetings, I finally made it to Cairo for ISCO 2026!

Good to run into ESMO – European Society for Medical Oncology President Fabrice Andre with incoming EORTC – European Organisation for Research and Treatment of Cancer President Benjamin Besse to hear more about the collaborative work between Institute Gustave Roussy and colleagues across Egypt.

Department of Oncology, University of Oxford take note!

The standard has been really high, with fantastic and informed questions at both my sessions.

Thanks to Mohamed Yassin and Tamer El-Nahas for the invitation and beautiful book; next year I promise a longer visit!”

Elizabeth Smyth

Other articles about ISCO on OncoDaily.